Press Releases
Search
-
20 Oct 2016
bioMérieux – Business Review for the nine months ended September 30, 2016
10.3% organic sales growth for the first nine months of 2016, powered by the Americas and Asia-Pacific regions: Sales reached €1,512 million Up 7.1% as reported All strategic lines contributed to the ...
-
17 Oct 2016
Lyme disease diagnostic tests
Like other laboratories, bioMérieux has been summoned to appear before the Tribunal de Grande Instance de Paris by 45 patients to obtain compensations linked to anxiety allegedly “generated by a lack ...
-
11 Oct 2016
FilmArray® Respiratory Panel EZ is CLIA waived by the FDA
bioMérieux, a world leader in the field of in vitro diagnostics, announced that BioFire Diagnostics, LLC, its molecular biology affiliate, received U.S. Food and Drug Administration (FDA) 510(k) clear...
-
10 Oct 2016
BIOASTER, bioMérieux, ESPCI, GSK, Hospices Civils de Lyon and Sanofi join forces against sepsis
BIOASTER, the French accelerator of microbiology technology innovation, bioMérieux, ESPCI (College of Physics and Industrial Chemistry of the city of Paris), GSK, the Hospices Civils de Lyon (HCL) and...
-
31 Aug 2016
bioMérieux – First-Half 2016 Results
Strong growth in sales, up 10.9% at constant exchange rates and scope of consolidation: €1,001 million in sales Up 7.2% as reported Sharp 22% improvement in contributive operating income before non-re...
-
18 Jul 2016
bioMérieux – Second-Quarter 2016 Business Review
Strong growth in sales, up 10.9%, at constant exchange rates and scope of consolidation in the first half of 2016: Sales reached €1,001 million Up 7.2% as reported Growth continued to be led by the Am...
-
06 Jul 2016
bioMérieux enlarges its pathogen identification capability on VITEK® MS
With a database of more than 15,000 strains VITEK® MS improves clinical decision-making for infectious diseases...
-
01 Jul 2016
bioMerieux Receives FDA Clearance for Expanded Use of VIDAS® B•R•A•H•M•S PCT™ Test for Managing Sepsis Patients with elevated risk of mortality
Tracking PCT – a biomarker for bacterial infections – over time provides strong indication of likely mortality, enabling physicians to personalize care for high-risk patients...
-
01 Jun 2016
bioMérieux acquires Hyglos and expands its offering to the detection of endotoxins in pharmaceutical products
bioMérieux, a global player in in vitro diagnostics and world leader in industrial microbiological control, announces the acquisition of Hyglos, a Bernried (Germany) - based company specializing in th...
-
31 May 2016
bioMérieux and the Lyon Civil Hospitals strengthen their collaboration and expand their partnership to include Claude Bernard University Lyon 1
Two joint research laboratories focused on a common goal: advancing medical research for the benefit of patients...
-
20 Apr 2016
Information financière du 1er trimestre 2016
Solid growth in sales, up 11.5% at constant exchange rates and scope of consolidation €489 million in sales Up 9.1% as reported Americas (up 22.5%) confirms its role as a key growth driver for the Gro...
-
11 Apr 2016
bioMérieux and Antwerp University unveil the final results of the first Global Point Prevalence Survey1 of antibiotic use and resistance rates in hospitals
Huge discrepancies in antibiotic use practices between countries 2nd line antibiotics2 too frequently prescribed...
-
08 Apr 2016
FilmArray® Torch is now FDA cleared with all 4 existing FilmArray® Panels and the system gets CE marked
BioFire receives FDA clearances for FilmArray® Torch with FilmArray® Blood Culture Identification Panel, Gastrointestinal Panel and Meningitis/Encephalitis Panel FilmArray® Torch delivers high through...
-
22 Mar 2016
bioMérieux and COPAN announce the first commercial success of their collaboration for the automation and efficiency of microbiology laboratories
bioMérieux, a world leader in the field of in vitro diagnostics, and COPAN, a leading manufacturer of innovative pre-analytic solutions, are pleased to announce the first commercial success resulting ...
-
02 Mar 2016
bioMérieux – 2015 Financial Results
Strong sales dynamic in 2015, driving 7.1% organic growth for the year €1,965 million in sales Up 15.7% as reported Robust contributive operating income before non-recurring items: €260 million In lin...